The effect of sodium hyaluronate on dry eye and corneal epithelial thickness following cataract surgery

Int Ophthalmol. 2024 May 2;44(1):211. doi: 10.1007/s10792-024-03128-3.

Abstract

Purpose: To evaluate the effects of sodium hyaluronate drops on dry eye parameters and corneal epithelial thickness following cataract surgery.

Methods: The study included 84 patients who underwent uncomplicated phacoemulsification. In Group A, 0.15% sodium hyaluronate drops were added to the postoperative antibiotic/anti-inflammatory treatment. In Group B, only antibiotic/anti-inflammatory treatment was applied. Preoperatively and at 1 week and 1 month postoperatively, all the patients were evaluated in respect of tear break-up time (TBUT), the Schirmer test under anesthesia, the corneal fluorescein staining (CFS) score, mean central corneal thickness (CCT) and mean central corneal epithelial thickness (CCET), and the two groups were compared.

Results: A statistically significant difference was determined between the two groups at postoperative 1 month in respect of TBUT, Schirmer test, CFS score, and CCET (p < 0.01). In Group A, a statistically significant increase was determined in the TBUT and Schirmer values at 1 month postoperatively (p < 0.01, p = 0.01, respectively) and in Group B, these values were decreased compared to preoperatively (p < 0.01). The CCET was determined to be significantly thinner in Group B 1 month postoperatively (p < 0.01). A significant increase in CCT was observed in both groups at postoperative 1 week (p < 0.01) and preoperative values were reached at 1 month postoperatively.

Conclusion: In the patient group using sodium hyaluronate, significant differences were determined in all dry eye parameters and CCET. The use of hyaluronate sodium drops after cataract surgery was seen to improve dry eye parameters and contribute to a healthy ocular surface by ensuring continuity of the corneal epithelium.

Keywords: Corneal epithelial thickness; Dry eye; Phacoemulsification; Sodium hyaluronate.

MeSH terms

  • Aged
  • Cataract Extraction / methods
  • Dry Eye Syndromes* / diagnosis
  • Dry Eye Syndromes* / drug therapy
  • Epithelium, Corneal* / drug effects
  • Epithelium, Corneal* / pathology
  • Female
  • Humans
  • Hyaluronic Acid* / administration & dosage
  • Male
  • Middle Aged
  • Ophthalmic Solutions* / administration & dosage
  • Phacoemulsification* / methods
  • Postoperative Complications / prevention & control
  • Prospective Studies
  • Tears / metabolism
  • Viscosupplements / administration & dosage

Substances

  • Hyaluronic Acid
  • Ophthalmic Solutions
  • Viscosupplements